knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 00:09:05 - browse：236

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： When prostate cancer spreads, where it goes matters

entertainment

WSS

Readers respond to H5N1 and livestock movements, and more

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Second House panel advances two

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Second House panel advances two

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Supreme Court strikes down use of affirmative action

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

In age of alternative facts, a scholarly course on calling out crap

How to ethically and practically extend health care to all

Walensky prepares to leave CDC — and Congress — behind

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA scientists endorse Pfizer/BioNTech Covid

At least 13 dead in Texas as scorching temps continue

When waiting feels immoral: Empathy in the emergency department

focus

Cytokinetics CEO stresses company can launch heart drug on its own

Arc Institute generative AI designs new CRISPR systems

How I helped Pfizer think through the ethics of Viagra

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Arc Institute generative AI designs new CRISPR systems

leisure time

entertainment

hotspot

hotspot